These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Computational Exploration of Fluorocyclopentenyl-purines and-pyrimidines Derivatives as Potential Inhibitors of Epidermal Growth Factor Receptor (EGFR) for the Treatment of Breast Cancer. Abida Ejaz S; Sajjad Bilal M; Aziz M; Wani TA; Zargar S; Fayyaz A; Hassan S; Ahmed A; Al Kahtani HM; Siddique F Chem Biodivers; 2023 Dec; 20(12):e202301190. PubMed ID: 37963090 [TBL] [Abstract][Full Text] [Related]
7. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors. Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189 [TBL] [Abstract][Full Text] [Related]
8. Interaction and molecular dynamics simulation study of Osimertinib (AstraZeneca 9291) anticancer drug with the EGFR kinase domain in native protein and mutated L844V and C797S. Assadollahi V; Rashidieh B; Alasvand M; Abdolahi A; Lopez JA J Cell Biochem; 2019 Aug; 120(8):13046-13055. PubMed ID: 30916819 [TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735 [TBL] [Abstract][Full Text] [Related]
10. Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies. Kiriwan D; Seetaha S; Jiwacharoenchai N; Tabtimmai L; Sousa SF; Songtawee N; Choowongkomon K Chem Biol Drug Des; 2022 Mar; 99(3):456-469. PubMed ID: 34923743 [TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer. Anbuselvam M; Easwaran M; Meyyazhagan A; Anbuselvam J; Bhotla HK; Sivasubramanian M; Annadurai Y; Kaul T; Pappusamy M; Balasubramanian B J Biomol Struct Dyn; 2021 Aug; 39(12):4462-4471. PubMed ID: 32567493 [TBL] [Abstract][Full Text] [Related]
12. Ligand-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamic Studies of Dual Tyrosine Kinase Inhibitor of EGFR and VEGFR2. Sangande F; Julianti E; Tjahjono DH Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096664 [TBL] [Abstract][Full Text] [Related]
13. DFT, molecular docking and molecular dynamics simulation studies on some recent natural products revealing their EGFR tyrosine kinase inhibition potential. Erdogan T; Oguz Erdogan F J Biomol Struct Dyn; 2024 Apr; 42(6):2942-2956. PubMed ID: 37144731 [TBL] [Abstract][Full Text] [Related]
14. Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors. Al-Anazi M; Al-Najjar BO; Khairuddean M Molecules; 2018 Dec; 23(12):. PubMed ID: 30563058 [TBL] [Abstract][Full Text] [Related]
15. QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor. Bommu UD; Konidala KK; Pabbaraju N; Yeguvapalli S J Recept Signal Transduct Res; 2019 Feb; 39(1):18-27. PubMed ID: 31223050 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Benzamide-Chalcone Derivatives as EGFR/CDK2 Inhibitor: Synthesis, In-Vitro Inhibition, and Molecular Modeling Studies. Joshi A; Bhojwani H; Wagal O; Begwani K; Joshi U; Sathaye S; Kanchan D Anticancer Agents Med Chem; 2022; 22(2):328-343. PubMed ID: 33858315 [TBL] [Abstract][Full Text] [Related]
17. Ligand and structure based hierarchical virtual screening cascade for finding novel epidermal growth factor receptor inhibitors. Huo D; Sun Z; Wang M; Yan A Chem Biol Drug Des; 2024 Jan; 103(1):e14375. PubMed ID: 37849030 [TBL] [Abstract][Full Text] [Related]
18. Shi Z; Chen J; Guo X; Cheng L; Guo X; Yu T J Cancer Res Ther; 2018 Jan; 14(1):18-23. PubMed ID: 29516953 [TBL] [Abstract][Full Text] [Related]
19. Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies. Rehman ZU; Najmi A J Biomol Struct Dyn; 2024; 42(19):10489-10509. PubMed ID: 37707987 [TBL] [Abstract][Full Text] [Related]
20. Design of Potential IKK-β Inhibitors using Molecular Docking and Molecular Dynamics Techniques for their Anti-cancer Potential. Singh SP; Hussain I; Konwar BK; Deka RC; Singh CB Curr Comput Aided Drug Des; 2021; 17(1):83-94. PubMed ID: 31899679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]